Alpha-MSH

New to peptides? Start with what are peptides? and how do peptides work?

Overview

Alpha-melanocyte-stimulating hormone (alpha-MSH) is a natural peptide hormone, cut from the larger precursor protein POMC, that acts across a family of melanocortin receptors found throughout the body. Unlike most entries on this site, it is not a product sold for use but an endogenous signal — and it is the biology that several well-known synthetic peptides were designed to imitate.

Those imitators are what most people actually search for: afamelanotide (Melanotan I), Melanotan II, and bremelanotide (PT-141) are all melanocortin analogs that copy or extend alpha-MSH's natural actions. Understanding alpha-MSH is therefore the key to understanding how the tanning and sexual-desire peptides work, and why they behave the way they do.

Alpha-MSH sits at the center of several distinct systems — pigmentation, inflammation, appetite, and sexual function — because its receptors are distributed widely and each receptor subtype governs a different process. This breadth is what makes the melanocortin system such a rich, and sometimes unpredictable, drug target.

How it works

Alpha-MSH exerts its effects by binding melanocortin receptors, of which there are five subtypes (MC1R through MC5R), each concentrated in different tissues.

• Pigmentation. Acting on MC1R in skin melanocytes, alpha-MSH stimulates the production of melanin. This is the fundamental biology of tanning, and the pathway that afamelanotide and Melanotan II exploit to darken skin.
• Anti-inflammation. Alpha-MSH has broad anti-inflammatory and cytoprotective actions across many tissues, including the skin and the eye, mediated in part through other melanocortin receptor subtypes.
• Appetite and sexual function. Through central receptors, notably MC4R in the brain, the melanocortin system helps regulate appetite and sexual arousal. This central pathway is the one that bremelanotide (PT-141) targets to influence sexual desire.

Because a single hormone touches so many systems, analogs designed for one effect — tanning, say — can produce others, such as changes in appetite or arousal, which is a recurring theme in how the melanocortin drugs behave.

Research & benefits

A research subject, not a product

Alpha-MSH itself is studied as endogenous biology rather than marketed as a therapy. The research spans its central role in pigmentation and the wider consequences of the alpha-MSH and MC1R interaction beyond skin color, its non-pigmentary anti-inflammatory actions in the skin, and the multifunctional melanocortin system of the eye.

Why it matters to readers

For most people the practical importance of alpha-MSH is as the natural template behind the melanocortin drugs. Afamelanotide is an approved medicine for a rare light-sensitivity disorder; Melanotan II is an unapproved tanning chemical; and bremelanotide is an approved treatment for low sexual desire in certain women. All three make sense only in light of the alpha-MSH biology they are built upon.

Studying the natural hormone also helps explain the side-effect patterns of its analogs, since anything that broadly activates melanocortin receptors can influence pigmentation, appetite, and arousal at the same time.

Safety & status

Alpha-MSH is an endogenous hormone rather than a commercial product, so the practical safety questions attach to its synthetic analogs rather than to the natural peptide. Those analogs vary enormously in how well they have been studied and regulated — from an FDA-approved drug to an unapproved tanning chemical sold online — and each carries its own distinct risk profile.

Anyone interested in the real-world safety and legal standing of melanocortin peptides should look to the specific analog in question, since alpha-MSH itself is not marketed as an approved therapy. As a rule, the broad receptor activity that makes the melanocortin system therapeutically interesting is also why its drugs require careful, individual evaluation rather than blanket assumptions carried over from the natural hormone.

Frequently asked questions

References

Each source links to its original record — peer-reviewed studies, regulator pages, or reference texts, labelled by type. We summarize findings neutrally; a citation is a reference, not an endorsement, and not a claim that its authors reviewed this page.

1. Wu CS, Cioanca AV, Gelmi MC, et al. The multifunctional human ocular melanocortin system. Prog Retin Eye Res. 2023. Peer-reviewed study
2. Herraiz C, Martínez-Vicente I, Maresca V. The alpha-melanocyte-stimulating hormone/melanocortin-1 receptor interaction: A driver of pleiotropic effects beyond pigmentation. Pigment Cell Melanoma Res. 2021. Peer-reviewed study
3. Takeuchi S, Takahashi S, Okimoto R, et al. Avian melanocortin system: alpha-MSH may act as an autocrine/paracrine hormone. Ann N Y Acad Sci. 2003. Peer-reviewed study
4. Eves PC, Haycock JW. Melanocortin signalling mechanisms. Adv Exp Med Biol. 2010. Peer-reviewed study
5. Böhm M, Schiller M, Luger TA. Non-pigmentary actions of alpha-melanocyte-stimulating hormone — lessons from the cutaneous melanocortin system. Cell Mol Biol. 2006. Peer-reviewed study
6. Suominen A, Saldo Rubio G, Ruohonen S, et al. α-Melanocyte-stimulating hormone alleviates pathological cardiac remodeling via melanocortin 5 receptor. EMBO Rep. 2024. Peer-reviewed study

Alpha-MSH in reference databases: Wikipedia · Wikidata · PubChem